Search
for
Sort by
Research 331–360 of 1000+
- Idiopathic Hirsutism*
- Hair: What is New in Diagnosis and Management?
- Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
- 5α-Reduced glucocorticoids: a story of natural selection
- <i>Acorus calamus</i>: a bio-reserve of medicinal values
- Review of Fluconazole Properties and Analytical Methods for Its Determination
- Recent advances in oxasteroids chemistry
- Androgens and Antiandrogens
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- Hair loss and herbs for treatment
- Redefining hormone resistance in prostate cancer
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Interventions for female pattern hair loss
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease
- Inhibition of glycosphingolipid synthesis reverses skin inflammation and hair loss in ApoE−/− mice fed western diet
- Oxidative stress management in the hair follicle: Could targeting NRF2 counter age‐related hair disorders and beyond?
- Parkinson's disease and skin
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Innovative Uses for Zinc in Dermatology
- Androgen antagonists in androgen target tissues
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Prospective metabolic evaluation of 150 consecutive patients who underwent gastric exclusion
- A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia
- Male hormonal contraception: looking back and moving forward
- Group IID, IIE, IIF and III secreted phospholipase A2s
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Androgenetic alopecia; drug safety and therapeutic strategies
- Secondary cicatricial and other permanent alopecias
- Novel inhibitors of 5α-reductase